Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy

Neurology

Volumn 55, Issue 5 SUPPL. 1, 2000, Pages

  Yerby, M S ^a  

^a North Pacific Epilepsy Research   (United States)

Author keywords

Antiepileptic drug; Pregnancy; Women

Indexed keywords

ANTICONVULSIVE AGENT;

ARTICLE; DEVELOPMENTAL DISORDER; EPILEPSY; FEMALE; FEMALE INFERTILITY; FETUS MALFORMATION; FETUS MORTALITY; HORMONAL CONTRACEPTION; HUMAN; LOW BIRTH WEIGHT; NEWBORN HEMORRHAGIC DISEASE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; QUALITY OF LIFE;

EID: 0033822097     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. Incidence and prevalence
2. Neuropsychiatry
3. Weight gain patterns in patients with epilepsy, comparison of antiepileptic drugs
4. Felbamate monotherapy: Controlled trial in patients with partial onset seizures
5. Long-term effect of topiramate in refractory partial epilepsy
6. Unwanted effects of sodium valproate in the treatment of adult patients with epilepsy
7. Phenytoin and fosphenytoin
8. The effect of menstruation on seizure incidence
9. The role of estrogens in catamenial epilepsy
10. Effects of steroids on cerebral electrical activity: Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit
11. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy
12. Anticonvulsant activity on steroids, separability of anticonvulsant from hormone effects
13. Epilepsy and menstruation: The role of water retention
14. Catamenial epilepsy
15. Analysis of seizure dispersion during menstrual cycle in women with epilepsy
16. Influence of menstruation on epilepsy
17. How common is catamenial epilepsy?
18. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle
19. Patterns of seizure occurrence in catamenial epilepsy
20. Three patterns of catamenial epilepsy
21. Catamenial epilepsy: A review
22. Unbalanced progesterone and estradiol secretion in catamenial epilepsy
23. Hormonal disregulation and catamenial epilepsy
24. Treatment of seizures with medroxyprogesterone acetate: Preliminary report
25. Medroxyprogesterone acetate in the treatment of seizures associated with menstruation
26. Progesterone therapy in women with complex partial and secondary generalized seizures
27. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders
28. Clomiphene therapy in epileptic women with menstrual disorders
29. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin
30. Use of oral contraceptives by women with epilepsy
31. Epilepsy and pregnancy
32. Pregnancy complications and outcomes in a cohort of women with epilepsy
33. Serum prolactin in epilepsy and hysteria
34. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: Social and biologic influences
35. Sexual dysfunction in epilepsy
36. Reproductive endocrine disorders in women with primary generalized epilepsy
37. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
38. Altered pulsatile secretion of luteinizing hormone in women with epilepsy
39. Pregnancy and epilepsy
40. Epilepsy and pregnancy: A study of 153 pregnancies in 59 patients
41. Higher risk of seizures in offspring of mothers than of fathers with epilepsy
42. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children
43. Epilepsy in pregnancy: Developmental outcome of offspring at 12 months
44. Epilepsy and pregnancy. A review of the literature and a study of thirty-seven cases
45. A survey of the relation between epilepsy and pregnancy
46. Epilepsy and pregnancy
47. Seizure states and pregnancy
48. Effect of pregnancy, childbirth and the puerperium on the course of epilepsy
49. Epilepsy and pregnancy
50. The influence of pregnancy on the course of epilepsy
51. Modifications of seizure frequency in pregnant patients with epilepsy: A prospective study
52. Change of seizure frequency in pregnant epileptic women
53. Risk factors for the increased seizure frequency during pregnancy and puerperium
54. Anticonvulsants during pregnancy and lactation: Transplacental, maternal and neonatal pharmacokinetics
55. Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding
56. Maternal epilepsy and congenital malformations: Correlation with maternal plasma anticonvulsant levels during pregnancy
57. Antiepileptic drugs and pregnancy: Altered utilization patterns and teratogenesis
58. The effect of pregnancy on the natural history of epilepsy: A review of the literature
59. Status epilepticus in pregnancy: Effect of phenytoin malabsorption on seizure control
60. Plasma protein binding of drugs in pregnancy
61. Antiepileptic drugs: Metabolism in pregnancy
62. The epileptic mother and her child
63. Relation of epileptic symptoms to pregnancy, delivery and puerperium
64. Effects of pregnancy on antiepileptic drug utilization
65. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy paralleled by changes in pattern of malformations
66. Seizures, anticonvulsants, and pregnancy
67. Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring
68. Epilepsy in pregnancy
69. Pregnancy and fetal complications in epileptic pregnancies: Review of the literature
70. Diagnosis of intracranial hemorrhage in utero after a maternal seizure
71. Fetal heart rate during a maternal grand mal epileptic seizure
72. Are anti-epileptic drugs harmful when given during pregnancy?
73. Maternal epilepsy and abnormalities of the fetus and the newborn
74. The course and outcome of pregnancy in women with epilepsy
75. Epilepsy and pregnancy: A report from the Oxford Record Linkage Study
76. Congenital malformation among infants of epileptic mothers treated during pregnancy - The report of a collaborative study group in Japan
77. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of a collaborative study group in Japan
78. A register study of maternal epilepsy and delivery outcome with special reference to drug use
79. Epilepsy, pregnancy, and major birth anomalies: An Italian prospective, controlled study
80. Fetal death, malformations and infant mortality in infants of mothers with epilepsy
81. Embryopathy during pregnancy caused by taking anticonvulsants
82. Teratogenicity of anticonvulsant drugs I: Review of the literature
83. Facial clefts in sibs and children of epileptic patients
84. Maternal valproic acid and congenital neural tube defects
85. Spina bifida in infants of women treated with carbamazepine during pregnancy
86. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs
87. In-utero exposure to valproate and neural tube defects
88. Pregnancy and birth in women with epilepsy
89. Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure
90. Nouveaux aspects de la maladie hemorragique du nouveau ne
91. Neonatal coagulation defect due to anticonvulsant treatment in pregnancy
92. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother
93. Do anticonvulsants have a teratogenic effect?
94. Infants exposed in utero to antiepileptic drugs: A prospective study
95. Premature delivery, gestational age, complications of delivery, vital data at birth on newborn infants of epileptic mothers: Review of the literature
96. Antiepileptics and the development of congenital anomalies
97. Congenital malformations and seizure disorders in the offspring of parents with epilepsy
98. Effect of seizures during pregnancy on seizure susceptibility in offspring
99. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects
100. Further experience of vitamin supplementation for prevention of neural tube defect recurrences
101. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience
102. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
103. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
104. Instructions for use of the reference guide